264 related articles for article (PubMed ID: 12900404)
1. Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation.
Charest PG; Bouvier M
J Biol Chem; 2003 Oct; 278(42):41541-51. PubMed ID: 12900404
[TBL] [Abstract][Full Text] [Related]
2. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
[TBL] [Abstract][Full Text] [Related]
3. The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling.
Charest PG; Oligny-Longpré G; Bonin H; Azzi M; Bouvier M
Cell Signal; 2007 Jan; 19(1):32-41. PubMed ID: 16857342
[TBL] [Abstract][Full Text] [Related]
4. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
5. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2.
Zhao M; Wimmer A; Trieu K; Discipio RG; Schraufstatter IU
J Biol Chem; 2004 Nov; 279(47):49259-67. PubMed ID: 15364949
[TBL] [Abstract][Full Text] [Related]
6. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis.
Ge L; Ly Y; Hollenberg M; DeFea K
J Biol Chem; 2003 Sep; 278(36):34418-26. PubMed ID: 12821670
[TBL] [Abstract][Full Text] [Related]
7. Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation.
Oligny-Longpré G; Corbani M; Zhou J; Hogue M; Guillon G; Bouvier M
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):E1028-37. PubMed ID: 22493236
[TBL] [Abstract][Full Text] [Related]
8. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*.
Oakley RH; Laporte SA; Holt JA; Barak LS; Caron MG
J Biol Chem; 2001 Jun; 276(22):19452-60. PubMed ID: 11279203
[TBL] [Abstract][Full Text] [Related]
10. Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor.
Jones BW; Hinkle PM
J Biol Chem; 2005 Nov; 280(46):38346-54. PubMed ID: 16183993
[TBL] [Abstract][Full Text] [Related]
11. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
[TBL] [Abstract][Full Text] [Related]
12. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
13. Role of G protein-coupled receptor kinase 4 and beta-arrestin 1 in agonist-stimulated metabotropic glutamate receptor 1 internalization and activation of mitogen-activated protein kinases.
Iacovelli L; Salvatore L; Capobianco L; Picascia A; Barletta E; Storto M; Mariggiò S; Sallese M; Porcellini A; Nicoletti F; De Blasi A
J Biol Chem; 2003 Apr; 278(14):12433-42. PubMed ID: 12519791
[TBL] [Abstract][Full Text] [Related]
14. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.
Shenoy SK; Lefkowitz RJ
J Biol Chem; 2003 Apr; 278(16):14498-506. PubMed ID: 12574160
[TBL] [Abstract][Full Text] [Related]
15. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
Estall JL; Koehler JA; Yusta B; Drucker DJ
J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
[TBL] [Abstract][Full Text] [Related]
16. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
17. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR.
Miller WE; Houtz DA; Nelson CD; Kolattukudy PE; Lefkowitz RJ
J Biol Chem; 2003 Jun; 278(24):21663-71. PubMed ID: 12668664
[TBL] [Abstract][Full Text] [Related]
18. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.
Kohout TA; Nicholas SL; Perry SJ; Reinhart G; Junger S; Struthers RS
J Biol Chem; 2004 May; 279(22):23214-22. PubMed ID: 15054093
[TBL] [Abstract][Full Text] [Related]
19. Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation.
Kumari P; Srivastava A; Ghosh E; Ranjan R; Dogra S; Yadav PN; Shukla AK
Mol Biol Cell; 2017 Apr; 28(8):1003-1010. PubMed ID: 28228552
[TBL] [Abstract][Full Text] [Related]
20. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
